16 Recruiting Trials

Clinical Trials
for COPD in Colorado

16 clinical trials for COPD are currently recruiting participants at study sites in Colorado. Study-related care is provided at no cost.

16
Recruiting trials
15
Study sites
6
Cities
9
Industry-sponsored
5
Phase 2
4
Phase 3

COPD clinical trials in Colorado: what to expect

COPD trials test new inhaler combinations, biologic injections for people whose flare-ups continue despite inhalers, and treatments for the cough and mucus that come with chronic bronchitis. Others study pulmonary rehabilitation and exercise, valves and other procedures for emphysema, home oxygen and remote monitoring, and programs to stop smoking. Most enroll people with moderate to severe disease who still have symptoms on their current treatment.

In Colorado, recruiting copd studies are concentrated in Denver, Aurora, Lakewood and Boulder, with sites in 2 other cities. 9 of the 16 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who COPD trials usually look for

Trials confirm COPD with a breathing test at screening and set a range for lung function, usually between 30 and 80 percent of predicted. Most ask for a smoking history of at least ten pack-years, though current smokers are generally accepted. Biologic trials require one or two flare-ups in the past year needing steroids or antibiotics and sometimes a blood eosinophil count above a threshold. Common exclusions are asthma as the main diagnosis, another significant lung disease and a flare-up in the past four weeks. Ages are usually 40 to 80.

What taking part involves

Screening includes spirometry, blood work and a symptom questionnaire, then a short run-in while you record symptoms. Drug trials run six to twelve months with visits every four to twelve weeks, breathing tests, a six-minute walk in some, and a diary or app. Your maintenance inhalers continue, sometimes replaced by study-supplied versions, and rescue inhaler is always allowed. Rehabilitation trials involve two or three sessions a week for eight to twelve weeks. Study care is free and visits are usually paid.

Questions worth asking the study team

Whether your inhalers stay the same; how breathing tests and walking tests are scheduled; the chance of placebo; what to do during a flare-up while enrolled; and whether oxygen users are accepted.

Showing 16 of 16 recruiting COPD trials in Colorado

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
PHASE2 Aurora, Colorado +4 sites NCT07684820
This trial is looking for people with chronic obstructive pulmonary disease (COPD) who have had recent flare-ups of their condition. Participants will take either the study drug or a placebo every day for a year.
Recruiting
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
PHASE2 Denver, Colorado +4 sites NCT07059091
This trial is looking for individuals with Chronic Obstructive Pulmonary Disease (COPD) and allergies. Participants will take a medication called omalizumab for about a year and have follow-up calls afterwards.
Recruiting
SPIROMICS Study of Early COPD Progression (SOURCE)
N/A Denver, Colorado +4 sites NCT05033990
This trial is looking for people aged 30-55 to study early chronic obstructive pulmonary disease (COPD). Participants will undergo tests like breathing tests and provide samples to help researchers understand who is at risk of developing COPD.
Recruiting
Phenotyping Resting and Exertional Right Ventricular Dysfunction Among Patients With Chronic Obstructive Pulmonary Disease
NA Aurora, Colorado NCT05896579
This trial is looking for people with chronic obstructive pulmonary disease (COPD) to learn more about how their heart works during rest and exercise. Participants will undergo some tests related to their heart and lungs to help find better treatments for COPD in the future.
Recruiting
Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary Disease
NA Aurora, Colorado NCT07576894
This trial is looking for individuals with chronic obstructive pulmonary disease (COPD) to study how their heart responds during rest and exercise. Taking part involves testing heart function while exercising at different intensity levels.
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
PHASE3 Athens, Alabama +4 sites NCT06283966
This trial is looking for adults aged 40 to 80 with Chronic Obstructive Pulmonary Disease (COPD). Participants will receive a combination inhaler treatment and attend study visits for assessments.
Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
PHASE2 Birmingham, Alabama +4 sites NCT07082738
This trial is looking for people with moderate to very severe COPD to test the effects of a new drug called AZD6793. Participants will take AZD6793 or a placebo and help researchers learn about its safety and effectiveness.
Recruiting
MoblO2 to Maintain Oxygenation
NA Denver, Colorado NCT07704567
This trial is looking for patients with chronic lung disease who use supplemental oxygen during physical activities. Participants will use oxygen tanks for two weeks while being monitored.
Recruiting
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
PHASE3 Aurora, Colorado +4 sites NCT06961214
This trial is looking for adults with moderate to severe COPD and type 2 inflammation. Participants will be taking depemokimab as an additional treatment along with their current medications.
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
PHASE3 Birmingham, Alabama +4 sites NCT07190222
This trial is looking for adults aged 40 to 80 with chronic obstructive pulmonary disease (COPD) that is not well controlled. Participants will receive either lunsekimig or a placebo for about 48 weeks, followed by an 8-week follow-up.
Recruiting
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
PHASE3 Lakewood, Colorado +4 sites NCT07177339
This trial is looking for adults with moderate to severe COPD who have certain inflammation in their lungs, and who are at risk for worsening symptoms. They need to have been diagnosed for at least a year and must not have had any serious lung issues in the past month. It's important that they don't have asthma or other significant lung diseases and aren’t currently using supplemental oxygen.
Recruiting
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
PHASE2 Denver, Colorado +4 sites NCT07759245
This trial is looking for adults with moderate-to-severe COPD to test a new treatment called Brenipatide. Participants will receive either the treatment or a placebo and will be monitored for about one year.
Recruiting
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
PHASE2 Aurora, Colorado +4 sites NCT05937854
This trial is looking for veterans with Chronic Obstructive Pulmonary Disease (COPD) and high blood pressure in the lungs who experience shortness of breath. Participants will take either the drug tadalafil or a placebo and will be monitored over six months to see if their breathing improves.
Recruiting
PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
NA Denver, Colorado +2 sites NCT05306743
This trial is looking for primary care teams to participate in a quality improvement program for patients with chronic obstructive pulmonary disease (COPD). Teams will either receive the program or usual care and will help evaluate the program's effects over three years.
Recruiting
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
NA Loveland, Colorado +4 sites NCT06035120
This trial is looking for people aged 40 to 80 with severe emphysema who have certain breathing issues. Participants will receive a treatment called AeriSeal Foam and may have a valve placed to help improve lung function, with follow-up for two years.
Recruiting
PiMZ Longitudinal Cohort (PiMZ Logic)
N/A Denver, Colorado +4 sites NCT06505603
This trial is looking for adults with a specific genetic condition called PiMZ alpha-1 antitrypsin deficiency who have breathing problems. Participants will undergo lung scans and provide health information to help understand their condition better.
Recruiting

Where the COPD studies are in Colorado

  • National Jewish Health, Denver4 trials
  • University of Colorado Anschutz Medical Campus, Aurora2 trials
  • Alpine Clinical Research Center - Boulder - 47th Street- Site Number : 8400005, Boulder1 trial
  • Critical Care Pulmonary & Sleep Associates- Site Number : 8400081, Lakewood1 trial
  • GSK Investigational Site, Aurora1 trial
  • GSK Investigational Site, Lakewood1 trial

Counts are recruiting studies listing at least one site in Colorado, from ClinicalTrials.gov, refreshed every two days.

COPD clinical trials in Colorado: common questions

How many COPD clinical trials are recruiting in Colorado?
TrialFinder currently lists 16 recruiting COPD clinical trials with study sites in Colorado. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are COPD clinical trials located in Colorado?
Study sites for the COPD trials listed on this page include Aurora, Denver, Lakewood, Loveland. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a COPD clinical trial in Colorado?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many COPD trials in Colorado also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a COPD clinical trial in Colorado?
Each study sets its own criteria based on age, COPD diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Do I need to quit smoking to join a COPD trial?
Most COPD trials accept current smokers; some require that you have stopped, and smoking-cessation trials are specifically for people who still smoke. The listing states the rule.
What tests confirm COPD for a trial?
Spirometry, a breathing test done at the site before and after a bronchodilator, which gives the lung function figure trials use to set their range. You do not need recent results to ask.
Will I keep using my inhalers during a trial?
Yes. Trials add the study treatment to your maintenance inhalers or supply a standardized equivalent, and a rescue inhaler is always permitted.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to COPD trials near you in Colorado.

Get Matched — Free
No insurance required

COPD trials investigate bronchodilators, anti-inflammatory biologics, pulmonary rehabilitation, and lung-volume reduction procedures for chronic obstructive lung disease.

All COPD trials →